Understand the source comparison
Brain Stimuilation vs Blood Flow
Most conventional ED treatments target blood flow. They enhance nitric oxide signaling and amplify the cGMP pathway inside penile smooth muscle. This increases arterial inflow and supports erection maintenance. For many men, this is sufficient. But blood flow
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Most conventional ED treatments target blood flow.
- They enhance nitric oxide signaling and amplify the cGMP pathway inside penile smooth muscle. This increases arterial inflow and supports erection maintenance.
- For many men, this is sufficient.
- But blood flow is only one component of erectile function.
- If the brain does not generate strong sexual signaling, the vascular system has nothing to amplify. A drug that increases nitric oxide cannot create desire. It cannot create arousal. It cannot initiate motivation.
- PT-141 functions differently.
- By stimulating melanocortin pathways in the brain, it acts as a potent initiator of sexual signaling. Once the neural signal strengthens, the downstream vascular signaling becomes more responsive.
- This distinction explains why some men who fail traditional ED treatments respond better to melanocortin-based peptide therapy.
- It also explains why combination and stacking strategies are sometimes used. A central activator paired with a vascular enhancer can address both components of erectile dysfunction simultaneously.